Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Labtec
Labtec
Activities:
Drug Delivery
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Distribution
Autoscribe chooses Labtec Egypt as distributor
Over the years Labtec has expanded its activity to serve more and more QC and R&D labs across a broad range of market segments
Packaging
Labtec opens facility for patches and oral films
Plant is certified as GMP-compliant and has room for expansion
Regulatory
APR and Labtec seek Zolmitriptan ODF approval in EU
Product will be manufactured in Hamburg, Germany
Drug Delivery
Labtec and GSK finalise licence agreement
GlaxoSmithKline obtains exclusive rights for an innovative topical patch to treat cold sores
Drug Delivery
Ondansetron RapidFilm gains European approval
Suitable for children and adults with swallowing difficulties
Subscribe now